KMT2A oncoproteins induce epigenetic resistance to targeted therapies.
Janssens DH, Duran M, Otto DJ, Wu W, Xu Y, Kirkey D, Mullighan CG, Yi JS, Meshinchi S, Sarthy JF, Ahmad K, Henikoff S.
Janssens DH, et al. Among authors: henikoff s.
bioRxiv [Preprint]. 2024 Aug 12:2023.12.29.573681. doi: 10.1101/2023.12.29.573681.
bioRxiv. 2024.
PMID: 38234854
Free PMC article.
Preprint.